TY - JOUR
T1 - Clinical characteristics and disease course in black patients with lymphomatoid papulosis
T2 - A case series
AU - Geller, Shamir
AU - Noor, Sarah J.
AU - Myskowski, Patricia L.
N1 - Publisher Copyright:
Copyright © 2020
PY - 2020/1
Y1 - 2020/1
N2 - Introduction: Lymphomatoid papulosis (LyP) is a CD30+ T-cell lymphoproliferative disorder (LPD) presenting as a recurrent eruption of papules and nodules which resolve spontaneously. CD30+ LPD prevalence in African American (AA)/Black patients is lower compared to White patients. CD30+ LPD has been recently reported to have worse outcomes in AA patients compared to White patients. Methods: A retrospective chart review identified eight AA patients with LyP. We describe our experience with these eight patients and review the literature on similar cases. Results: In half of the eight included patients, lesions occurred 1-4 years before they were diagnosed. In six patients (75%), resolution of the lesions resulted in hyperpigmented macules and scars. Five patients (63%) had also mycosis fungoides. Most of the patients who were followed (4/7, 57%) did not have complete resolution at their last visit, despite different treatment approaches. Discussion: Our results highlight that although LyP has an indolent course in AA/Black patients, residual hyperpigmentation and scars frequently occur, highlighting the need for better treatments of this lymphoproliferative disorder in this specific population.
AB - Introduction: Lymphomatoid papulosis (LyP) is a CD30+ T-cell lymphoproliferative disorder (LPD) presenting as a recurrent eruption of papules and nodules which resolve spontaneously. CD30+ LPD prevalence in African American (AA)/Black patients is lower compared to White patients. CD30+ LPD has been recently reported to have worse outcomes in AA patients compared to White patients. Methods: A retrospective chart review identified eight AA patients with LyP. We describe our experience with these eight patients and review the literature on similar cases. Results: In half of the eight included patients, lesions occurred 1-4 years before they were diagnosed. In six patients (75%), resolution of the lesions resulted in hyperpigmented macules and scars. Five patients (63%) had also mycosis fungoides. Most of the patients who were followed (4/7, 57%) did not have complete resolution at their last visit, despite different treatment approaches. Discussion: Our results highlight that although LyP has an indolent course in AA/Black patients, residual hyperpigmentation and scars frequently occur, highlighting the need for better treatments of this lymphoproliferative disorder in this specific population.
UR - http://www.scopus.com/inward/record.url?scp=85079078363&partnerID=8YFLogxK
U2 - 10.36849/JDD.2020.4602
DO - 10.36849/JDD.2020.4602
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32023015
AN - SCOPUS:85079078363
SN - 1545-9616
VL - 19
SP - 89
EP - 91
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 1
ER -